Thus, careful monitoring of cardiac function and fluid status is strongly recommended during the treatment of patients with heart failure, as observed in three reports [13,22,23], which also recommend considering systemic and pulmonary congestion and monitoring NT-proBNP serum levels in these patients [23]. The gene discussed is NPPB; the disease is heart failure.